TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan · Delayed Price · Currency is TWD 9.69
+0.02 (0.21%)
Sep 5, 2025, 1:30 PM CST
TPEX:4157 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -242.17 | -38.58 | 136.73 | -237.16 | 775.62 | -404.82 | Upgrade |
Depreciation & Amortization | 22.57 | 24.77 | 27.48 | 28.46 | 28.74 | 30.86 | Upgrade |
Other Amortization | 0.06 | 0.06 | 0.13 | 0.09 | 0.12 | 0.57 | Upgrade |
Loss (Gain) From Sale of Assets | 2.29 | - | - | - | 0.08 | -0.01 | Upgrade |
Asset Writedown & Restructuring Costs | 3.79 | 1.96 | - | 12.06 | - | 2.92 | Upgrade |
Loss (Gain) From Sale of Investments | -6.1 | -13.55 | -165.22 | -0.3 | -0.08 | -0.43 | Upgrade |
Loss (Gain) on Equity Investments | - | - | - | - | 23.24 | 113.04 | Upgrade |
Stock-Based Compensation | 4.37 | 32.48 | 25 | -4.99 | 40.03 | 14.44 | Upgrade |
Provision & Write-off of Bad Debts | - | - | 7.6 | - | - | - | Upgrade |
Other Operating Activities | 52.78 | -63.1 | 1.22 | -60.88 | 40.07 | -20.94 | Upgrade |
Change in Accounts Receivable | -1.19 | 1.65 | 1.83 | 260.02 | -272.8 | -5.44 | Upgrade |
Change in Inventory | 3.57 | -8.24 | -18.75 | 3.29 | -4.35 | -7.13 | Upgrade |
Change in Accounts Payable | -12.92 | 1.96 | 0.66 | -17.33 | 10.49 | -1.49 | Upgrade |
Change in Unearned Revenue | -0.1 | -0.15 | -0.15 | -0.16 | -44.41 | 44.06 | Upgrade |
Change in Income Taxes | - | - | - | - | 26.29 | 0.29 | Upgrade |
Change in Other Net Operating Assets | -5.27 | 3.37 | -9.05 | -4.37 | -2.68 | -2.26 | Upgrade |
Operating Cash Flow | 84.88 | -173.09 | 7.46 | -21.27 | 629.07 | -242.1 | Upgrade |
Capital Expenditures | -0.53 | -0.53 | -3.89 | -3.39 | -10.24 | -5.46 | Upgrade |
Sale of Property, Plant & Equipment | 2.53 | - | - | - | 0.11 | 0.01 | Upgrade |
Sale (Purchase) of Intangibles | -2.98 | -2.16 | -3.51 | -4.07 | -1.6 | -2.95 | Upgrade |
Investment in Securities | -287.21 | -136.22 | 138.44 | -81.62 | -298.07 | 216.76 | Upgrade |
Other Investing Activities | 29.11 | 28.04 | 14.42 | 4.13 | 3.73 | 7.74 | Upgrade |
Investing Cash Flow | -259.09 | -110.87 | 145.46 | -84.95 | -306.07 | 216.1 | Upgrade |
Short-Term Debt Issued | - | - | - | 3 | - | - | Upgrade |
Total Debt Issued | 35 | - | - | 3 | - | - | Upgrade |
Short-Term Debt Repaid | - | - | -3 | - | - | -30 | Upgrade |
Long-Term Debt Repaid | - | -15.98 | -16.99 | -17.99 | -18.61 | -19.07 | Upgrade |
Total Debt Repaid | -16.15 | -15.98 | -19.99 | -17.99 | -18.61 | -49.07 | Upgrade |
Net Debt Issued (Repaid) | 18.85 | -15.98 | -19.99 | -14.99 | -18.61 | -49.07 | Upgrade |
Issuance of Common Stock | - | - | - | - | - | 0.02 | Upgrade |
Other Financing Activities | -1.61 | -1.42 | -1.14 | -0.85 | -0.24 | -0.6 | Upgrade |
Financing Cash Flow | 17.25 | -17.4 | -21.12 | -15.84 | -18.85 | -49.65 | Upgrade |
Foreign Exchange Rate Adjustments | -0.76 | 0.84 | -0.25 | 0.24 | -0.07 | 0.25 | Upgrade |
Net Cash Flow | -157.72 | -300.52 | 131.55 | -121.82 | 304.08 | -75.4 | Upgrade |
Free Cash Flow | 84.34 | -173.62 | 3.57 | -24.66 | 618.83 | -247.56 | Upgrade |
Free Cash Flow Margin | 207.32% | -115.25% | 2.90% | -68.06% | 47.80% | -1056.95% | Upgrade |
Free Cash Flow Per Share | 0.12 | -0.24 | 0.01 | -0.03 | 0.86 | -0.34 | Upgrade |
Cash Interest Paid | 1.61 | 1.42 | 1.14 | 0.85 | 0.24 | 0.6 | Upgrade |
Cash Income Tax Paid | - | 5.1 | 9.83 | 32.22 | 72.51 | 3.23 | Upgrade |
Levered Free Cash Flow | -135.67 | -18.62 | -84.51 | 57.08 | 366.39 | -111.98 | Upgrade |
Unlevered Free Cash Flow | -134.67 | -17.73 | -83.8 | 57.61 | 366.55 | -111.61 | Upgrade |
Change in Working Capital | 247.29 | -117.13 | -25.47 | 241.45 | -278.76 | 22.25 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.